NO995932D0 - Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetes - Google Patents
Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetesInfo
- Publication number
- NO995932D0 NO995932D0 NO995932A NO995932A NO995932D0 NO 995932 D0 NO995932 D0 NO 995932D0 NO 995932 A NO995932 A NO 995932A NO 995932 A NO995932 A NO 995932A NO 995932 D0 NO995932 D0 NO 995932D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- gestational diabetes
- polycystic ovarian
- ovarian syndrome
- thiazolidinedione derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/868,608 US6046222A (en) | 1993-09-15 | 1997-06-04 | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
PCT/US1998/010472 WO1998055121A1 (en) | 1997-06-04 | 1998-05-21 | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995932D0 true NO995932D0 (no) | 1999-12-03 |
NO995932L NO995932L (no) | 1999-12-03 |
Family
ID=25352002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995932A NO995932L (no) | 1997-06-04 | 1999-12-03 | Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetes |
Country Status (15)
Country | Link |
---|---|
US (3) | US6046222A (no) |
EP (1) | EP0984780B1 (no) |
JP (1) | JP2002511859A (no) |
KR (1) | KR20010013337A (no) |
AT (1) | ATE303147T1 (no) |
BR (1) | BR9809968A (no) |
CA (1) | CA2283319A1 (no) |
DE (1) | DE69831406D1 (no) |
HU (1) | HUP0003876A3 (no) |
IL (1) | IL131801A0 (no) |
IS (1) | IS5194A (no) |
NO (1) | NO995932L (no) |
PL (1) | PL348773A1 (no) |
WO (1) | WO1998055121A1 (no) |
ZA (1) | ZA984798B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046222A (en) * | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US20020177612A1 (en) * | 1997-06-05 | 2002-11-28 | Smithkline Beecham P.I.C. | Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
US20020006939A1 (en) * | 1997-10-13 | 2002-01-17 | Smithkline Beecham P.L.C. | Use of thiazolidinediones for the treatment of hyperglycaemia |
US20010031776A1 (en) * | 1997-10-13 | 2001-10-18 | Smithkline Beecham P.L.C. | Use of thiazolidinediones for the treatment of hyperglycaemia |
US7105552B2 (en) * | 1998-05-08 | 2006-09-12 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
US6605642B2 (en) | 1999-04-05 | 2003-08-12 | City Of Hope | Inhibitors of formation of advanced glycation endproducts (AGES) |
US7030133B2 (en) | 1999-04-05 | 2006-04-18 | City Of Hope | Inhibitors of formation of advanced glycation endproducts (AGEs) |
US7407978B2 (en) * | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
CA2371391A1 (en) * | 1999-04-29 | 2000-11-09 | City Of Hope | Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
US6468507B1 (en) * | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
ATE334718T1 (de) * | 2000-10-30 | 2006-08-15 | Ortho Mcneil Pharm Inc | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln |
EP1392326B1 (en) * | 2001-04-04 | 2009-09-09 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
DE60231295D1 (de) * | 2001-04-04 | 2009-04-09 | Ortho Mcneil Janssen Pharm | R und ppar modulatoren |
GB0108863D0 (en) * | 2001-04-10 | 2001-05-30 | Leuven K U Res & Dev | Combinational therapy |
US20030212138A1 (en) * | 2002-01-14 | 2003-11-13 | Pharmacia Corporation | Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
KR100450700B1 (ko) * | 2002-03-22 | 2004-10-01 | 주식회사종근당 | 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물 |
US20030220300A1 (en) * | 2002-05-14 | 2003-11-27 | Hwang Cheng Shine | Reduction of hair growth |
WO2003105809A1 (en) | 2002-06-17 | 2003-12-24 | Themis Laboratories Private Limited | Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
WO2004100895A2 (en) * | 2003-05-13 | 2004-11-25 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders |
AU2004287434B2 (en) | 2003-10-27 | 2011-04-07 | City Of Hope | Methods of lowering lipid levels in a mammal |
US20050112075A1 (en) * | 2003-11-25 | 2005-05-26 | Hwang Cheng S. | Reduction of hair growth |
US20050249685A1 (en) * | 2004-04-27 | 2005-11-10 | Natalia Botchkareva | Reduction of hair growth |
US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
CN101087583A (zh) * | 2004-12-22 | 2007-12-12 | 吉莱特公司 | 用生存素抑制剂来减少毛发生长 |
US20070032781A1 (en) * | 2004-12-22 | 2007-02-08 | Henry James P | Reduction of hair growth |
US7618956B2 (en) * | 2005-05-31 | 2009-11-17 | The Gillette Company | Reduction of hair growth |
US20070249561A1 (en) * | 2006-04-25 | 2007-10-25 | Taylor Bradley K | Pharmacological method for treatment of neuropathic pain |
EP2254576B1 (en) * | 2008-02-22 | 2013-08-28 | The Ohio State University Research Foundation | Androgen receptor-ablative agents |
EP3871671A3 (en) | 2009-07-29 | 2022-03-09 | Olsen, Elise | Fp receptor antagonists for inhibiting hair growth |
US8383656B2 (en) | 2009-10-09 | 2013-02-26 | The Ohio State University Research Foundation | Thiazolidinedione energy restriction-mimetic agents |
GB201518979D0 (en) * | 2015-10-27 | 2015-12-09 | Univ Leuven Kath | Treatment of hepatic steatosis related oligo-ovulation |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3174901A (en) * | 1963-01-31 | 1965-03-23 | Jan Marcel Didier Aron Samuel | Process for the oral treatment of diabetes |
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
FR2449446A1 (fr) * | 1979-02-22 | 1980-09-19 | Somachim | Medicament a base d'acide iodothyroacetiques et de sel de metformine |
JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
US4703052A (en) * | 1985-05-21 | 1987-10-27 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
FI91869C (fi) * | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
EP0295828A1 (en) * | 1987-06-13 | 1988-12-21 | Beecham Group Plc | Novel compounds |
US5260445A (en) * | 1987-09-04 | 1993-11-09 | Beecham Group P.L.C. | 2,4-thiazolidinediones |
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
US5232925A (en) * | 1987-09-04 | 1993-08-03 | Beecham Group P.L.C. | Compounds |
US5194443A (en) * | 1987-09-04 | 1993-03-16 | Beecham Group P.L.C. | Compounds |
MX15171A (es) * | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
US5120754A (en) * | 1988-03-08 | 1992-06-09 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
US5061717A (en) * | 1988-03-08 | 1991-10-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
US4897405A (en) * | 1989-04-21 | 1990-01-30 | American Home Products Corporation | Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents |
GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
GB8919434D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
WO1991003474A1 (en) * | 1989-08-29 | 1991-03-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
DE3942236A1 (de) * | 1989-12-21 | 1991-06-27 | Bosch Siemens Hausgeraete | Katalytisches ueberzugsmittel, verfahren zu seiner herstellung und mit dem ueberzugsmittel erhaeltliche koch-, back-, brat- oder grillgeraete oder teile |
JP3544659B2 (ja) * | 1990-02-09 | 2004-07-21 | ファルマシア・アンド・アップジョン・カンパニー | インスリン感性化剤類の高血圧治療のための使用 |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
GB9023585D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
GB9023583D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
US5221685A (en) * | 1991-02-01 | 1993-06-22 | Ube Industries, Ltd. | Thiazoline derivative, process for preparing the same and chemical for controlling noxious organisms containing the same |
ES2092112T3 (es) * | 1991-06-25 | 1996-11-16 | Pfizer | Agentes hipoglicemicos de tiazolidindiona. |
EP0603419A4 (en) * | 1992-07-13 | 1994-10-12 | Japan Tobacco Inc | NEW THIAZOLIDINEDIONE COMPOUND AND ITS USE. |
US5221686A (en) * | 1992-08-04 | 1993-06-22 | American Home Products Corporation | Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents |
MD1486G2 (ro) * | 1992-10-29 | 2001-11-30 | Genentech, Inc. | Metodă de tratament sau profilaxie a obezităţii |
US6046222A (en) * | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5874454A (en) * | 1993-09-15 | 1999-02-23 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
ATE376829T1 (de) * | 1993-09-15 | 2007-11-15 | Daiichi Sankyo Co Ltd | Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm) |
-
1997
- 1997-06-04 US US08/868,608 patent/US6046222A/en not_active Expired - Fee Related
-
1998
- 1998-05-21 KR KR19997011333A patent/KR20010013337A/ko not_active Application Discontinuation
- 1998-05-21 WO PCT/US1998/010472 patent/WO1998055121A1/en active IP Right Grant
- 1998-05-21 BR BR9809968-0A patent/BR9809968A/pt not_active IP Right Cessation
- 1998-05-21 AT AT98923660T patent/ATE303147T1/de not_active IP Right Cessation
- 1998-05-21 CA CA002283319A patent/CA2283319A1/en not_active Abandoned
- 1998-05-21 HU HU0003876A patent/HUP0003876A3/hu unknown
- 1998-05-21 DE DE69831406T patent/DE69831406D1/de not_active Expired - Lifetime
- 1998-05-21 JP JP50250999A patent/JP2002511859A/ja active Pending
- 1998-05-21 EP EP98923660A patent/EP0984780B1/en not_active Expired - Lifetime
- 1998-05-21 PL PL98348773A patent/PL348773A1/xx unknown
- 1998-05-21 IL IL13180198A patent/IL131801A0/xx unknown
- 1998-06-03 ZA ZA984798A patent/ZA984798B/xx unknown
- 1998-07-29 US US09/124,707 patent/US5972944A/en not_active Expired - Fee Related
-
1999
- 1999-09-24 IS IS5194A patent/IS5194A/is unknown
- 1999-11-16 US US09/440,997 patent/US6130216A/en not_active Expired - Fee Related
- 1999-12-03 NO NO995932A patent/NO995932L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6046222A (en) | 2000-04-04 |
ATE303147T1 (de) | 2005-09-15 |
EP0984780A1 (en) | 2000-03-15 |
IS5194A (is) | 1999-09-24 |
CA2283319A1 (en) | 1998-12-10 |
IL131801A0 (en) | 2001-03-19 |
PL348773A1 (en) | 2002-06-17 |
WO1998055121A1 (en) | 1998-12-10 |
US6130216A (en) | 2000-10-10 |
HUP0003876A2 (hu) | 2002-01-28 |
DE69831406D1 (de) | 2005-10-06 |
NO995932L (no) | 1999-12-03 |
KR20010013337A (ko) | 2001-02-26 |
US5972944A (en) | 1999-10-26 |
ZA984798B (en) | 1998-12-29 |
JP2002511859A (ja) | 2002-04-16 |
BR9809968A (pt) | 2000-08-01 |
HUP0003876A3 (en) | 2002-04-29 |
EP0984780B1 (en) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995932D0 (no) | Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetes | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
DK1174135T3 (da) | Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes | |
ATE414514T1 (de) | Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend | |
PT1333887E (pt) | Metodo de tratamento de desordens musculares | |
NO20041203L (no) | Human glukagonlignende peptid-1 etterligner og deres anvendelse i behandling av diabetes og relaterte tilstander. | |
MY180762A (en) | Combination therapy comprising glucose reabsorption inhibitors and ppar modulators. | |
DK1202736T3 (da) | Nikotin i terapeutisk angiogenese og vasculogenese | |
NO996314D0 (no) | Fremgangsmåte for behandling av tobakk for å redusere nitrosamin-innholdet og produkter som fremstilles derved | |
CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
NL300288I2 (nl) | Behandeling van diabetes met thiazolidinedion en metformine. | |
MY140132A (en) | Thiazolidin-4-one derivatives for use in the treatment of anemias | |
NO20005387D0 (no) | 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer | |
HUP9802721A1 (hu) | Eljárás és készítmény a hiperurikémia kezelésére és megelőzésére | |
NO20020793L (no) | Virkestoffkombinasjon med clonidin | |
NO20040726L (no) | Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav. | |
NO20033498D0 (no) | Fremgangsmåte for behandling og törking av trevirke | |
IS6033A (is) | Tálmar við amínótransferasa, sem háðir eru amínósýru með greinóttum keðjum, og notkun þeirra til meðhöndlunar á sjónusjúkdómum af völdum sykursýki | |
NO980221L (no) | Fremgangsmåte for behandling av tykktarmsadenomer | |
DK0796618T3 (da) | Behandling og profylakse af pankreatitis | |
NO20020031L (no) | Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi | |
DK0479093T3 (da) | Oligosaccharidderivater og deres anvendelse som lægemidler | |
NO984572D0 (no) | Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e | |
EP1567476A4 (en) | N-OXIDES AND DERIVATIVES OF MELPHALAN FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS RELATED TO THE INDUCIBLE FACTOR OF HYPOXIA | |
NO20000229L (no) | Behandling av diabetes med tiazolidindion og sulfonylurea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |